OVERVIEW

15th Annual T-Cell Lymphoma Forum is organized by University of Virginia (UVA) School of Medicine and will be held from Jun 06 - 08, 2024 at Hilton La Jolla Torrey Pines, La Jolla, California, United States of America.

Description:
The 15th Annual T-Cell Lymphoma Forum is a three-day meeting focusing on the latest information on novel agents and treatment approaches. The Forum provides a composite platform to facilitate progress in TCL research by addressing the hurdles that have confronted oncologists and ultimately paves the way for improved outcomes for patients. The comprehensive agenda includes the most relevant topics that will deepen your understanding of these complex diseases and impact your care of patients.

Desired Outcomes:
At the conclusion of this conferece, participants will be able to:
• Identify T-Cell Lymphoma patient profiles who are likely to benefit from receiving novel or emerging treatments, or enrollment in a clinical trial, independent of their age, gender, or race. 
• Evaluate the most recent clinical trial data for emerging therapeutic options and novel agents for newly diagnosed T Cell Lymphoma cases as well as relapsed/refractory T-cell lymphomas
• Integrate both single-agent or combination targeted therapy into patient care plans for those with T-cell lymphomas
• Identify important aspects of individualized treatment pathways for patients with T-cell lymphomas by using assessment of their molecular/phenotypic biomarkers and accurate lymphoma subclassification, while leveraging best practices, guidelines, recommendations in this therapeutic area.
• Identify and manage patients with treatment-related adverse events through agent familiarity and best practices in robust monitoring efforts.

Conference Topics:
• Epidemiology and Classification
• Molecular Biology and Pathogenesis
• T-Cell Lymphoma Subtypes
• Management and Treatment
• Cutaneous T-Cell Lymphoma
• International Guidelines
• Industry Innovations
• Selected Poster and Oral Abstracts

KEY DATES

Event Start Date
06 Jun, 2024
Event Start Date
Event End Date
08 Jun, 2024
Event End Date
Credits

Accreditation and Designation Statement
In support of improving patient care, this activity has been planned and implemented by Virginia Department of Health and the University of Virginia School of Medicine and School of Nursing is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

The University of Virginia School of Medicine and School of Nursing designates this live activity for maximum of 9.50 AMA PRA Category1 Credits.™

 

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

The University of Virginia School of Medicine and School of Nursing awards 9.5 hours of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)™or ANCC contact hours) to a participant who successfully completes this educational activity. The University of Virginia School of Medicine and School of Nursing maintains a record of participation for six (6) years.

  • 9.5 AMA PRA Category 1
  • 9.5 Contact Hours
  • 9.5 Hours
  • TARGET AUDIENCE

    PhysicianClinical PharmacologyBio-Pharma CompaniesDrug developersHealthcare ProvidersPharmacoepidemiologyDrug Research & DevelopmentResearch scientistsMedical OncologistsOncological Nursing Staff

    SPECIALITIES

    Hematology Blood and Marrow TransplantHaematologyOncology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationHilton La Jolla Torrey Pines
    10950 N Torrey Pines Rd

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235